SCHEMBL29678802

SCHEMBL29678802

O=C(O)c1c(O)ccc2cc(F)ccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
KDM4E B2RXH2 4/20 0.44
HPGD P15428 4/20 0.44
HSD17B10 Q99714 4/20 0.44
CYP2C19 P33261 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
CYP1A2 P05177 1/20 0.44
GLA P06280 1/20 0.44
DHODH Q02127 8/20 0.42
LCK P06239 1/20 0.41
LMNA P02545 2/20 0.41
PDPK1 O15530 1/20 0.41
TSHR P16473 1/20 0.41
NFKB1 P19838 1/20 0.41
APEX1 P27695 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA12 O43570 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23640322 0.84 PTPN1 (0.43) ALDH1A1HPGDMEN1KMT2ALCK
SCHEMBL30178354 0.81 CA12 (0.48) ALDH1A1KDM4EHPGDHSD17B10CYP2C19
SCHEMBL732139 0.81 CA12 (0.48) ALDH1A1KDM4EHPGDHSD17B10CYP2C19
SCHEMBL13573125 0.81 CA1 (0.50) ALDH1A1KDM4EHPGDHSD17B10CYP2C19
SCHEMBL3914003 0.80 KDM4E (0.53) ALDH1A1KDM4EHPGDHSD17B10CYP2C19
SCHEMBL4028463 0.79 ERN1 (0.56) ALDH1A1KDM4EHPGDHSD17B10CYP2C19
SCHEMBL3871771 0.79 KDM4E (0.52) ALDH1A1KDM4EHPGDHSD17B10CYP2C19
SCHEMBL19203353 0.79 CSNK2A1 (0.52) ALDH1A1KDM4EHPGDHSD17B10CYP2C19
Hydrochloric Acid SCHEMBL3914780 0.79 KDM4E (0.52) ALDH1A1KDM4EHPGDHSD17B10CYP2C19
SCHEMBL24895100 0.78 MPL (0.50) ALDH1A1KDM4EHPGDHSD17B10CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022068921-A1 QUINAZOLINE COMPOUND AND APPLICATION THEREOF 上海医药集团股份有限公司 2022-04-07 WO disclosed